NCT04010929 is a NA clinical trial of Partial pulpotomy with laser+MTA in Laser, sponsored by Merve Erkmen Almaz.

Who is sponsoring NCT04010929?

NCT04010929 is sponsored by Merve Erkmen Almaz.

What drugs are being tested in NCT04010929?

Interventions in NCT04010929: Partial pulpotomy with laser+MTA, Partial pulpotomy with MTA.

What condition does NCT04010929 study?

NCT04010929 studies Laser, Tooth, Pulpotomy.

Is NCT04010929 still recruiting?

NCT04010929 is currently completed. Last updated 8 July 2019.

Last reviewed 2019-07-08 · How we verify

NCT04010929

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Er,Cr:YSGG Laser in Partial Pupotomy

Completed NA Last updated 8 July 2019

What this trial tests

NA trial testing Partial pulpotomy with laser+MTA in Laser in 64 participants. Completed in 14 January 2019.

Timeline

8 January 2018

Primary endpoint
14 January 2019

14 January 2019

Quick facts

Lead sponsor	Merve Erkmen Almaz
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	64
Start date	8 January 2018
Primary completion	14 January 2019
Estimated completion	14 January 2019
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Partial pulpotomy with laser+MTA
Partial pulpotomy with MTA

Conditions studied

Laser — all drugs for Laser →
Tooth — all drugs for Tooth →
Pulpotomy — all drugs for Pulpotomy →

Sponsor

Merve Erkmen Almaz — full company profile →

Who can join

Adults 6 to 15, any sex, with Laser or Tooth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to compare the efficacy of partial pulpotomy treatment using MTA and Er,Cr:YSGG + MTA in permanent immature molar teeth with deep dentin caries. The study was performed in children aged between 6-15 who had at least one deep dentine caries in permanent immature molar tooth. The patients' therapies were completed in Kırıkkale University, Faculty of Dentistry, Department of Pediatric Dentisry. A total of 90 teeth (caries exposed) were included in the study. According to the treatment, the teeth were randomly divided into two groups: 1. MTA group (n=45), 2. Laser+MTA group (n=45). In the MTA group, after removing caries, MTA was applied to the exposed area on the pulp following bleeding control with 5.25% NaOCl. In the same session, the tooth was restored with resin modified glass ionomer cement and composite resin. In the laser+MTA group, the treatment procedures were the same as the MTA group, and before the MTA condensation, Er, Cr: YSGG laser was applied to the exposure area after bleeding control to provide biostimulation. Patients were called for followup appointments at 1, 3, 6 and 12 months after treatment and control radiographs were taken.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Laser

Currently open trials in the same condition.

NCT07519421 — Different Laser Frequencies on Neuropathic Outcomes in Patients With Bell's Palsy · NA · recruiting
NCT07566507 — High-Energy Laser in the Conservative Treatment of Rhizarthrosis · NA · recruiting
NCT07467954 — Comparative Effectiveness of Long-Pulsed 1064-nm Nd:YAG and Fractional CO₂ Laser in Skin Rejuvenation · NA · recruiting
NCT07517601 — Erbium-doped Yttrium Aluminum Garnet (Er:YAG) Laser vs Conventional Ceramic Bracket Debonding: A Split-Mouth Clinical Tr · NA · active not recruiting
NCT07351747 — Effect of Laser Acupoints on Fallopian Tube Obstruction · NA · recruiting

Other Merve Erkmen Almaz trials

Trials by the same sponsor.

NCT04298996 — Effect of Passive Smoking on Oxidative Stress and Dental Caries in Children · completed
NCT04292548 — Salivary TAS, TOS, LL-37 and Dental Status in Passive Smoking Children · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04010929 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Merve Erkmen Almaz
Last refreshed: 8 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04010929.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing